Burden of non‐motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa‐carbidopa intestinal gel

BACKGROUND AND PURPOSE: GLORIA, a registry conducted with 375 advanced Parkinson's disease patients treated with levodopa‐carbidopa intestinal gel (LCIG) for 24 months in routine clinical care, demonstrated significant reductions from baseline in ‘off’ time and ‘on’ time with dyskinesia and imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray Chaudhuri, K., Antonini, A., Robieson, W. Z., Sanchez‐Soliño, O., Bergmann, L., Poewe, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590168/
https://www.ncbi.nlm.nih.gov/pubmed/30353942
http://dx.doi.org/10.1111/ene.13847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590168/
https://www.ncbi.nlm.nih.gov/pubmed/30353942
http://dx.doi.org/10.1111/ene.13847

Ejemplares similares